Market Insights Health OTC Pharmaceuticals

Analgesics - Equatorial Guinea

Equatorial Guinea

In Equatorial Guinea, the revenue in the Analgesics market is calculated to be US$4.51m in 2024.
According to projections, the market is anticipated to witness an annual growth rate of 1.08% (CAGR 2024-2029).
When comparing globally, the in the United States generates the highest revenue in this market, reaching US$7,243.00m in 2024.
In terms of per capita income, each individual in Equatorial Guinea generates revenues of US$2.57 in 2024.
Equatorial Guinea's analgesics market is experiencing a surge in demand due to the growing awareness of self-medication among its population.

Key regions: Brazil, Europe, Germany, Canada, United States

Market

Region

Region comparison

Currency

Analyst Opinion

The Analgesics market in Equatorial Guinea is experiencing steady growth due to various factors.

Customer preferences: Equatorial Guinea has a growing population that is becoming more health-conscious. As a result, there is an increasing demand for analgesic products to alleviate pain and discomfort. Customers in Equatorial Guinea prefer over-the-counter analgesics as they are easily accessible and do not require a prescription. Additionally, customers tend to favor analgesics that provide quick relief and have minimal side effects.

Trends in the market: One of the major trends in the analgesics market in Equatorial Guinea is the shift towards natural and herbal remedies. Customers are becoming more aware of the potential side effects of synthetic analgesics and are seeking alternative options. This has led to the rise in popularity of herbal analgesics that are perceived to be safer and have fewer adverse effects.Another trend in the market is the increasing availability of analgesics in different formats. Customers in Equatorial Guinea now have a wide range of options to choose from, including tablets, capsules, creams, gels, and patches. This allows them to select the format that best suits their needs and preferences.

Local special circumstances: Equatorial Guinea is a country with a high prevalence of infectious diseases, such as malaria and dengue fever. These diseases often cause symptoms such as fever and body aches, which can be effectively managed with analgesics. As a result, there is a consistent demand for analgesics in the country.

Underlying macroeconomic factors: Equatorial Guinea has experienced significant economic growth in recent years, driven by its oil and gas industry. This has led to an increase in disposable income among the population, allowing them to spend more on healthcare products, including analgesics.Furthermore, the government of Equatorial Guinea has been investing in improving healthcare infrastructure and services. This has resulted in better access to healthcare facilities and increased awareness about the importance of managing pain and discomfort.In conclusion, the Analgesics market in Equatorial Guinea is growing steadily due to the increasing health-consciousness among the population, the shift towards natural and herbal remedies, the availability of analgesics in different formats, the prevalence of infectious diseases, and the country's economic growth and investment in healthcare.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.